E-Mail Alert

Add your e-mail address to receive forthcoming issues of this journal:

Journal Browser

Journal Browser

Special Issue "Marine Drugs in Clinical Trials"

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (15 February 2018)

Special Issue Editor

Guest Editor
Dr. David J. Newman

Retired Chief of Natural Product Branch at the National Cancer Institute at the National Institutes of Health, USA
Phone: +1 610 971 9784
Interests: marine metabolites as drug leads and clinical candidates; marine microbiology; bioinformatics

Special Issue Information

Dear Colleagues,

The aim of this Special Issue is to demonstrate the utility of marine-sourced materials (from invertebrates, microbes of all types, and micro- and macro-algae as sources of such agents). Compounds should have reached the preclinical stage and be candidates for clinical trials in humans, though, depending on their source, agents at the preclinical stage can be considered on their merits.

Dr. David John Newman
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • Marine invertebrate-sourced candidates
  • Marine plant-sourced candidates
  • Marine algae
  • Marine microbes (culturable)
  • Marine microbes (not yet cultured)

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to Top